Skip to content
You can now search across every topic, entity and event.What's new
Pandemics and Biosecurity
16JUN

US bans entry from DRC, Uganda, S Sudan

3 min read
10:26UTC

On 18 May the United States imposed a 21-day entry ban on nationals of three African states, including green-card holders, three days before WHO formally advised against exactly such restrictions.

ScienceDeveloping
Key takeaway

The US entry ban runs against live WHO advice for the first time since the 2014 Ebola response.

On 18 May the United States imposed a 21-day entry ban on nationals of the Democratic Republic of Congo, Uganda and South Sudan, including green-card holders 1. US citizens may still enter but face enhanced public-health screening at George Bush Intercontinental Airport in Houston from 26 May 2. South Sudan was included despite having no confirmed Bundibugyo cases, on the stated logic of porous borders with the DRC 3. The measure followed three days after WHO declared the Bundibugyo emergency .

The ban came first; four days later WHO's Emergency Committee issued Temporary Recommendations advising against travel and trade restrictions, and the ban has not been lifted since 4. Africa CDC publicly opposed the restrictions on 19 May 5. A major power has now banned travel against live WHO advice during an active emergency for the first time since the West Africa Ebola crisis of 2014, whose travel-ban failures the IHR exit-screening model was written to replace.

Entry bans push exposed travellers toward unscreened land routes and onward third-country flights, the exact behaviour exit screening at source is built to capture, and they discourage the honest disclosure border co-operation depends on. Bans also operate on nationality rather than exposure: a green-card holder WHO has not left the US in a year falls under the bar, while the screening of returning US citizens at Houston targets actual travel history. The 21-day entry ban therefore catches people by passport, not by where they have been.

Washington's reach for a border measure rather than a deployment has a structural backdrop. The USAID outbreak-response unit that would have surged personnel to Ituri had already been disbanded before the emergency , leaving entry restriction as one of the few levers still readily available. For readers planning travel, the practical effect is narrow: the bar falls on green-card holders and nationals of the three countries, while US citizens face questions and a temperature check at Houston, not exclusion.

Deep Analysis

In plain English

On 18 May 2026, the United States banned entry for nationals of three countries: the Democratic Republic of Congo, Uganda, and South Sudan. The ban includes people with US permanent residency (green cards). South Sudan was included even though no Ebola cases had been confirmed there. Public-health experts consistently oppose travel bans during Ebola outbreaks because they do not stop the virus, they drive sick or worried people to use unofficial routes where they cannot be monitored. They also make healthcare workers from affected countries reluctant to volunteer to help, which is exactly the opposite of what a response needs. Four days after the ban was imposed, the WHO's own expert committee formally recommended against travel or trade restrictions.

Deep Analysis
Root Causes

The US entry ban tracks a structural gap left by the dismantling of USAID's outbreak-response unit: with no 90-person CDC field presence deployable to Ituri, the only publicly visible US action available is a border measure. Entry bans are administratively simple and politically legible; field surge deployment requires an institutional apparatus the current US government no longer has.

South Sudan's inclusion despite zero cases reflects the conflation of geographic proximity with epidemic risk. The Ituri-South Sudan border does carry genuine surveillance risk given ungated population movement, but including South Sudan in a travel ban without a confirmed case is epidemiologically unjustifiable and was designed to signal political decisiveness rather than epidemiological precision.

What could happen next?
  • Risk

    Travel bans that push affected-country nationals to use informal border crossings reduce the WHO's ability to conduct exit screening, the single most evidence-based border measure for Ebola.

  • Consequence

    Uganda and South Sudan nationals working abroad in healthcare roles may delay return to their countries of origin, reducing the human resource pool available for the Ituri response surge.

First Reported In

Update #4 · Ebola triples, response misfires

STAT News· 24 May 2026
Read original
Different Perspectives
Indian Council of Medical Research
Indian Council of Medical Research
ICMR deployed a team to Kerala within hours of the 11 June Nipah confirmation in Kozhikode, tracing roughly 100 contacts including 58 healthcare workers; three days without fresh positives suggest containment of a pathogen with no licensed vaccine and a case-fatality rate of 40 to 75 percent.
ECDC / European Union
ECDC / European Union
ECDC's Week 23 Communicable Disease Threats Report carried four simultaneous non-Ebola signals including the first peer-reviewed evidence of Dermatophilus congolensis sexual transmission, local mpox clade Ib European spread, and the Dermatophilus rapid risk assessment due 23 June. European import risk for Bundibugyo is assessed as very low.
United States (HHS / State Department)
United States (HHS / State Department)
Washington committed $270 million bilaterally to the response on 12 June while its 30-day entry ban on DRC, Uganda and South Sudan nationals, extended to green-card holders on 5 June, expired around 17 June unresolved. The CDC's R0=2.51 modelling is the sharpest analytical contribution to the response from any national agency.
World Health Organization
World Health Organization
DON607's publication on 13 June provides the 695-case international reference and attributes the treatment trial design to national leadership rather than WHO advisory consensus; the WHO co-authors the Continental Strategic Plan with Africa CDC but holds no enforcement lever over the US entry ban expiring 17 June.
Uganda Ministry of Health
Uganda Ministry of Health
Diana Atwine's ministry traced the 14-imported-case Uganda cluster using protocols rehearsed in the 2022 Sudan ebolavirus containment of 142 cases in 113 days; Uganda co-authorises the treatment trial and Bwera border lab reduces cross-border confirmation to same-day. Nineteen confirmed cases with five from onward Kampala transmission test whether the Sudan playbook transfers.
DRC Ministry of Health
DRC Ministry of Health
Kinshasa's 14 June bulletin counted 782 confirmed cases with 45.9 percent isolated, a figure DRC's health minister has linked directly to ongoing attacks on treatment facilities rather than community resistance. DRC co-leads the clinical trial now under national authority, a regulatory posture that keeps Geneva's timeline advisory, not binding.